| Direkt Wettbewerbsvergleich | |
|---|
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Unternehmen | Ticker | Preis | Veränd. | Marktkap. | KGV |
|---|
| Amgen Inc. | AMGN | 105,63 | 0,01 | 79,22Mrd. | 17,88 |
|---|
| Genentech, Inc. | "Privat" |
|---|
| Biogen Idec Inc. | BIIB | 226,85 | -0,01 | 53,85Mrd. | 36,00 |
|---|
| Genzyme Corporation | "Privat" |
|---|
| Merck Serono S.A. | "Privat" |
|---|
| Gilead Sciences Inc. | GILD | 56,30 | 0,02 | 85,88Mrd. | 31,52 |
|---|
| MedImmune, L.L.C. | "Privat" |
|---|
| Life Technologies Corporation | LIFE | 73,54 | 0,00 | 12,65Mrd. | 31,13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40,23 | 0,01 | 34,28Mrd. | 20,08 |
|---|
| Sandoz International GmbH | "Privat" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Unternehmen | Ticker | Preis | Veränd. | Marktkap. | KGV |
|---|
| Actavis, Inc. | ACT | 125,50 | 0,02 | 16,03Mrd. | n.v. |
|---|
| Ranbaxy Laboratories Limited | "Privat" |
|---|
| Mylan, Inc. | MYL | 31,40 | 0,02 | 11,97Mrd. | 20,98 |
|---|
| Pfizer Inc. | PFE | 28,96 | -0,01 | 205,42Mrd. | 13,86 |
|---|
| Johnson & Johnson | JNJ | 88,09 | 0,01 | 247,43Mrd. | 23,92 |
|---|
| GlaxoSmithKline plc | GSK | 52,22 | 0,00 | 126,48Mrd. | 19,09 |
|---|
| Sanofi | SNY | 54,50 | 0,01 | 144,25Mrd. | 26,86 |
|---|
| Novartis AG | NVS | 74,15 | -0,01 | 182,20Mrd. | 18,82 |
|---|
| Roche Holding AG | RHHBY | 63,13 | -0,01 | 214,26Mrd. | 21,13 |
|---|
| AstraZeneca PLC | AZN | 51,56 | -0,01 | 64,45Mrd. | 11,40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Unternehmen | Ticker | Preis | Veränd. | Marktkap. | KGV |
|---|
| Abbott Laboratories | ABT | 36,59 | -0,01 | 57,04Mrd. | 11,15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43,30 | 0,01 | 71,12Mrd. | 49,04 |
|---|
|
| Nachrichten zu direkten Wettbewerbern | |
|---|
Kein direkter WettbewerbervergleichWährung in USD. | |
|
0,05(1,22%) 17. Mai 21:59